Standard Biotools (LAB) Free Cash Flow Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | -1.61% |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | -70.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.32% |
| Dec 31, 2025 | 54.27% |
| Sep 30, 2025 | 5.04% |
| Jun 30, 2025 | 20.06% |
| Mar 31, 2025 | -29.01% |
| Dec 31, 2024 | -179.35% |
| Sep 30, 2024 | 12.99% |
| Jun 30, 2024 | 0.34% |
| Mar 31, 2024 | -47.22% |
| Dec 31, 2023 | 7.83% |
| Sep 30, 2023 | -35.62% |
| Jun 30, 2023 | -43.63% |
| Mar 31, 2023 | -21.26% |
| Dec 31, 2022 | -49.06% |
| Sep 30, 2022 | -63.74% |
| Jun 30, 2022 | -78.56% |
| Mar 31, 2022 | 6.90% |
| Dec 31, 2021 | 8.75% |
| Sep 30, 2021 | -127.01% |
| Jun 30, 2021 | -106.35% |